Effect of LY2216684 on Ambulatory Heart Rate and Blood Pressure in Patients With Major Depressive Disorder Who Are Being Treated With Selective Serotonin Reuptake Inhibitors.
Phase of Trial: Phase I
Latest Information Update: 01 Apr 2011
At a glance
- Drugs Edivoxetine (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics
- 01 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Mar 2011 Planned end date changed from 1 May 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.
- 11 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.